Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Clinical trial NCT03549650 · TERMINATED

Trial details

NCT number: NCT03549650
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lower Urinary Tract Symptoms Bladder Carcinoma BCG

Start date: 2019-05-03
Primary completion: 2022-02-15
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.